CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
116 hedge funds and large institutions have $1.36B invested in Clovis Oncology, Inc. in 2013 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
6% less call options, than puts
Call options by funds: $18.1M | Put options by funds: $19.3M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
116
Holding in Top 10
2
Calls
$18.1M
Puts
$19.3M
Top Buyers
| 1 | +$23.9M | |
| 2 | +$23.2M | |
| 3 | +$17.6M | |
| 4 |
D.E. Shaw & Co
New York
|
+$16.2M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$13M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$20.1M | |
| 3 | -$16.6M | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$14.3M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$13.6M |